• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物在运动神经元病姑息治疗中的应用

Opioid medication in the palliative care of motor neurone disease.

作者信息

Oliver D

机构信息

Wisdom Hospice, Rochester, Kent, UK.

出版信息

Palliat Med. 1998 Mar;12(2):113-5. doi: 10.1191/026921698677326556.

DOI:10.1191/026921698677326556
PMID:9616447
Abstract

In the palliative care of patients with motor neurone disease (MND) symptoms are encountered that can be helped by the use of strong opioid medication. A retrospective survey of the 32 patients dying of MND at the Wisdom Hospice who required opioids showed that 75% received oral opioids, 94% received parenteral opioids and 72% received both oral and parenteral opioids. The median oral morphine dose was 60 mg/24 h, with a median duration of 51 days and the median parenteral dose was 180 mg/24 h with a median duration of use of three days. The results show that strong opioids can be used safely and effectively in the palliative care of patients with MND.

摘要

在运动神经元病(MND)患者的姑息治疗中,会出现一些可通过使用强效阿片类药物得到缓解的症状。对智慧临终关怀院32例死于MND且需要使用阿片类药物的患者进行的回顾性调查显示,75%的患者接受口服阿片类药物,94%的患者接受胃肠外阿片类药物,72%的患者同时接受口服和胃肠外阿片类药物。口服吗啡的中位剂量为60毫克/24小时,中位使用时长为51天,胃肠外给药的中位剂量为180毫克/24小时,中位使用时长为3天。结果表明,强效阿片类药物可安全有效地用于MND患者的姑息治疗。

相似文献

1
Opioid medication in the palliative care of motor neurone disease.阿片类药物在运动神经元病姑息治疗中的应用
Palliat Med. 1998 Mar;12(2):113-5. doi: 10.1191/026921698677326556.
2
Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis.运动神经元病/肌萎缩侧索硬化症终末期的药物治疗
Amyotroph Lateral Scler. 2010 Dec;11(6):562-4. doi: 10.3109/17482968.2010.493203. Epub 2010 Jun 22.
3
Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit.入院时过度使用透皮芬太尼。
Palliat Med. 2011 Mar;25(2):111-6. doi: 10.1177/0269216310384901. Epub 2010 Oct 11.
4
Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.呼吸困难、相对年轻以及每日阿片类药物剂量较低预示着晚期癌症患者生命最后一周阿片类药物剂量会增加。
Jpn J Clin Oncol. 2014 Nov;44(11):1082-7. doi: 10.1093/jjco/hyu137. Epub 2014 Sep 23.
5
A regional survey of opioid use by patients receiving specialist palliative care.对接受专科姑息治疗患者的阿片类药物使用情况进行的区域调查。
Palliat Med. 1995 Jul;9(3):229-38. doi: 10.1177/026921639500900308.
6
Dose ratios between high dose oral morphine or equivalents and oral methadone.高剂量口服吗啡或等效物与口服美沙酮的剂量比。
J Palliat Med. 2013 Aug;16(8):947-50. doi: 10.1089/jpm.2012.0434. Epub 2013 May 10.
7
Opioid use in dying patients in hospice and hospital, with and without specialist palliative care team involvement.临终关怀机构和医院中临终患者使用阿片类药物的情况,有无专业姑息治疗团队的参与。
Eur J Cancer Care (Engl). 2008 Jan;17(1):65-71. doi: 10.1111/j.1365-2354.2007.00810.x.
8
Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.姑息治疗患者经皮和口服阿片类药物的临床经验——一项回顾性研究。
Jpn J Clin Oncol. 2007 Apr;37(4):302-9. doi: 10.1093/jjco/hym017. Epub 2007 May 22.
9
Opioid switch in palliative care, opioid choice by clinical need and opioid availability.姑息治疗中的阿片类药物转换、根据临床需求选择阿片类药物以及阿片类药物的可及性。
Eur J Pain. 2005 Oct;9(5):571-9. doi: 10.1016/j.ejpain.2004.12.003. Epub 2005 Jan 20.
10
The care of the very old in the last three days of life.临终前三天的超高龄患者的护理。
J Palliat Med. 2011 Dec;14(12):1339-44. doi: 10.1089/jpm.2011.0308.

引用本文的文献

1
Efficacy of pain management strategies in adults with Amyotrophic Lateral Sclerosis (ALS): A Systematic Review.成人肌萎缩侧索硬化症(ALS)疼痛管理策略的疗效:系统评价。
Neurol Sci. 2024 Dec;45(12):5591-5604. doi: 10.1007/s10072-024-07643-0. Epub 2024 Jul 5.
2
Optimizing breathlessness management in amyotrophic lateral sclerosis: insights from a comprehensive systematic review.优化肌萎缩侧索硬化症呼吸困难的管理:来自综合系统评价的见解。
BMC Palliat Care. 2024 Apr 16;23(1):100. doi: 10.1186/s12904-024-01429-z.
3
Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy.
肌萎缩侧索硬化症与疼痛:从疼痛评估到治疗的叙事性综述。
Behav Neurol. 2024 Mar 16;2024:1228194. doi: 10.1155/2024/1228194. eCollection 2024.
4
High doses of opioids usage for amyotrophic lateral sclerosis patients with non-invasive ventilation.大剂量阿片类药物用于接受无创通气的肌萎缩侧索硬化症患者。
Acta Neurol Belg. 2024 Feb;124(1):101-107. doi: 10.1007/s13760-023-02344-5. Epub 2023 Aug 5.
5
Pain in amyotrophic lateral sclerosis: a narrative review.肌萎缩侧索硬化症中的疼痛:一项叙述性综述。
J Yeungnam Med Sci. 2022 Jul;39(3):181-189. doi: 10.12701/jyms.2022.00332. Epub 2022 Jun 8.
6
Palliative care for patients with motor neurone disease: current challenges.运动神经元病患者的姑息治疗:当前挑战
Degener Neurol Neuromuscul Dis. 2016 May 26;6:65-72. doi: 10.2147/DNND.S85103. eCollection 2016.
7
Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis.肌萎缩侧索硬化症的疾病修饰治疗与对症治疗
Ther Adv Neurol Disord. 2017 Oct 9;11:1756285617734734. doi: 10.1177/1756285617734734. eCollection 2018.
8
Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.肌萎缩侧索硬化症:2013 年的最新临床特征、病理生理学、管理和治疗试验。
Aging Dis. 2013 Oct 1;4(5):295-310. doi: 10.14336/AD.2013.0400295.
9
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease.肌萎缩侧索硬化症或运动神经元病疼痛的药物治疗
Cochrane Database Syst Rev. 2013 Jun 5;2013(6):CD005226. doi: 10.1002/14651858.CD005226.pub3.
10
Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.肌萎缩侧索硬化症:病理生理学、诊断与治疗。
CNS Drugs. 2011 Jan;25(1):1-15. doi: 10.2165/11586000-000000000-00000.